NR3C2 and neoplasm: To test the dependence of SARS-CoV-2 replication on inactivation of the MR proteins—termed Viral Checkpoint for analogy to tumor Checkpoints7—we adapted the OncoTreat algorithm8 to identify small molecule compounds capable of activating such MRs (ViroTreat, Fig. 2).